Has Michael Moore, MD received payments from drug or device companies?

Yes. Drug and device makers reported $90,435 in general payments to Michael Moore, MD across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Moore, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Moore, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Moore, MD

Neurology · Houston, TXNPI 1154827699

Payments from drug & device makers

What this record shows

This record is dominated by grants: $90,000 of the $90,435 with a category attached, or 99.5%. Biogen accounts for 99.6% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $90,094 and has fallen 99.9% since, to $111 in 2025. Among neurology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$90,435in general payments, 2019–2025

Across 11 payments — averaging $8221.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biogen$90K
AstraZeneca$125
EMD Serono, Inc.$111
Genentech, Inc.$105
Merz Pharmaceuticals, LLC$13

$20,106in research payments, 2019–2025

Across 2 payments — averaging $10,053 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AstraZeneca$20K

What the payments were for

Grants$90,000100%
Food & beverage$3240%
Education$1110%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biogen	6	$90,081
AstraZeneca	1	$125
EMD Serono, Inc.	2	$111
Genentech, Inc.	1	$105
Merz Pharmaceuticals, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OCREVUS$105

How this compares

$90,435 in reported general payments places this provider in the 90th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas →

Medicare billing

Part B allowed, 2024

$54,894

Medicare patients

Services billed

2,358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Kesimpta PenOfatumumab	18	$216,832
Dalfampridine ErDalfampridine	31	$3,744
Teriflunomide	24	$1,189
Gabapentin	40	$755
Baclofen	32	$555
Lacosamide	12	$527
Pregabalin	24	$297
Duloxetine Hcl	13	$285
Tizanidine Hcl	11	$201
Oxybutynin Chloride ErOxybutynin Chloride	14	$119

Paid to pharmacies, not to this prescriber.

Other neurology in Houston

William OndoHouston$1.4M
Pankaj SatijaHouston$1.1M
Annette HowardHouston$826K
Randolph EvansHouston$493K
Leorah FreemanHouston$401K
Mazen DimachkieHouston$388K
Zsila SadighiHouston$361K
Joseph JankovicHouston$323K
Raja MehannaHouston$300K
Eddie PattonHouston$299K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →